The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Varicella-zoster virus
Open accessAbstract
Varicella-zoster virus (VZV) is a ubiquitous human alphaherpesvirus that causes varicella (chicken pox) and herpes zoster (shingles). Varicella is a common childhood illness, characterized by fever, viremia, and scattered vesicular lesions of the skin. As is characteristic of the alphaherpesviruses, VZV establishes latency in cells of the dorsal root ganglia. Herpes zoster, caused by VZV reactivation, is a localized, painful, vesicular rash involving one or adjacent dermatomes. The incidence of herpes zoster increases with age or immunosuppression. The VZV virion consists of a nucleocapsid surrounding a core that contains the linear, double-stranded DNA genome; a protein tegument separates the capsid from the lipid envelope, which incorporates the major viral glycoproteins. VZV is found in a worldwide geographic distribution but is more prevalent in temperate climates. Primary VZV infection elicits immunoglobulin G (IgG), IgM, and IgA antibodies, which bind to many classes of viral proteins. Virus-specific cellular immunity is critical for controlling viral replication in healthy and immunocompromised patients with primary or recurrent VZV infections. Rapid laboratory confirmation of the diagnosis of varicella or herpes zoster, which can be accomplished by detecting viral proteins or DNA, is important to determine the need for antiviral therapy. Acyclovir is licensed for treatment of varicella and herpes zoster, and acyclovir, valacyclovir, and famciclovir are approved for herpes zoster. Passive antibody prophylaxis with varicella-zoster immune globulin is indicated for susceptible high-risk patients exposed to varicella. A live attenuated varicella vaccine (Oka/Merck strain) is now recommended for routine childhood immunization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Blacklow, N. R., Gorbach, S. L., & Bartlett, J. G. (1992) · Cited by 2,753
Lever, W. F., & Lippincott, J. B. (1950) · Plastic and Reconstructive Surgery · doi:10.1097/00006534-195005000-00012 · Cited by 2,664
The Complete DNA Sequence of Varicella-Zoster Virus
Davison, A. J., & Scott, J. E. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-9-1759 · Cited by 1,420
The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,386
Population-Based Study of Herpes Zoster and Its Sequelae
RAGOZZINO, M. W., MELTON, L. J., KURLAND, L. T., CHU, C. P., & PERRY, H. O. (1982) · Medicine · doi:10.1097/00005792-198209000-00003 · Cited by 926
Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases
Enders, G., Bolley, I., Miller, E., Cradock-Watson, J., & Ridehalgh, M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92943-2 · Cited by 693
Beutner, K. R., Friedman, D. J., Forszpaniak, C., Andersen, P. L., & Wood, M. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.7.1546 · Cited by 613
Tyring, S., Barbarash, R. A., Nahlik, J. E., Cunningham, A., Marley, J., Heng, M., Jones, T., Rea, T., Boon, R., Saltzman, R., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-2-199507150-00002 · Cited by 491
Hardy, I., Gershon, A. A., Steinberg, S. P., & LaRussa, P. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111283252204 · Cited by 452
Cited by
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Rahier, J. F., Ben-Horin, S., Chowers, Y., Conlon, C., De Munter, P., D'Haens, G., Domènech, E., Eliakim, R., Eser, A., Frater, J., et al. (2009) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.02.010 · Cited by 738
Heininger, U., & Seward, J. F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69561-5 · Cited by 564
Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
Strangfeld, A. (2009) · JAMA · doi:10.1001/jama.2009.146 · Cited by 542
Herpes Zoster OphthalmicusNatural History, Risk Factors, Clinical Presentation, and Morbidity
LIESEGANG, T. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.10.009 · Cited by 471
Marek's disease virus: from miasma to model
Osterrieder, N., Kamil, J. P., Schumacher, D., Tischer, B. K., & Trapp, S. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1382 · Cited by 411
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life
Johnson, R. W., Bouhassira, D., Kassianos, G., Leplège, A., Schmader, K. E., & Weinke, T. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-37 · Cited by 404
Passive immunity in prevention and treatment of infectious diseases
Keller, M. A., & Stiehm, E. R. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.602 · Cited by 388
A systematic review and meta-analysis of risk factors for postherpetic neuralgia
Forbes, H. J., Thomas, S. L., Smeeth, L., Clayton, T., Farmer, R., Bhaskaran, K., & Langan, S. M. (2016) · Pain · doi:10.1097/j.pain.0000000000000307 · Cited by 355
Evolution of the herpesviruses
Davison, A. J. (2002) · Veterinary Microbiology · doi:10.1016/s0378-1135(01)00492-8 · Cited by 336
Viral Pneumonias in Adults: Radiologic and Pathologic Findings
Kim, E. A., Lee, K. S., Primack, S. L., Yoon, H. K., Byun, H. S., Kim, T. S., Suh, G. Y., Kwon, O. J., & Han, J. (2002) · RadioGraphics · doi:10.1148/radiographics.22.suppl_1.g02oc15s137 · Cited by 326
Use of an Inactivated Varicella Vaccine in Recipients of Hematopoietic-Cell Transplants
Hata, A., Asanuma, H., Rinki, M., Sharp, M., Wong, R. M., Blume, K., & Arvin, A. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013441 · Cited by 300
Self-citationFletcher, J. M., Vukmanovic-Stejic, M., Dunne, P. J., Birch, K. E., Cook, J. E., Jackson, S. E., Salmon, M., Rustin, M. H., & Akbar, A. N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8218 · Cited by 296
Johnson, R. W., Alvarez-Pasquin, M.-J., Bijl, M., Franco, E., Gaillat, J., Clara, J. G., Labetoulle, M., Michel, J.-P., Naldi, L., Sanmarti, L. S., et al. (2015) · Therapeutic Advances in Vaccines · doi:10.1177/2051013615599151 · Cited by 288
Herpes zoster: Epidemiology, natural history, and common complications
Weinberg, J. M. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.08.046 · Cited by 278
Li, Z., Liu, T., Yang, N., Han, D., Mi, X., Li, Y., Liu, K., Vuylsteke, A., Xiang, H., & Guo, X. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0786-5 · Cited by 269
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
Tompa, D. R., Immanuel, A., Srikanth, S., & Kadhirvel, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.076 · Cited by 257
Directed Egress of Animal Viruses Promotes Cell-to-Cell Spread
Johnson, D. C., & Huber, M. T. (2002) · Journal of Virology · doi:10.1128/jvi.76.1.1-8.2002 · Cited by 257
Chlibek, R., Bayas, J. M., Collins, H., de la Pinta, M. L. R., Ledent, E., Mols, J. F., & Heineman, T. C. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jit365 · Cited by 149
Neuroimaging of herpesvirus infections in children
Baskin, H. J., & Hedlund, G. (2007) · Pediatric Radiology · doi:10.1007/s00247-007-0506-1 · Cited by 127
The characterization of varicella zoster virus-specific T cells in skin and blood during aging
Vukmanovic-Stejic, M., Sandhu, D., Seidel, J. A., Patel, N., Sobande, T. O., Agius, E., Jackson, S. E., Fuentes-Duculan, J., Suárez-Fariñas, M., Mabbott, N. A., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.63 · Cited by 117
“However, later in life VZV reactivation can occur, causing herpes zoster (also known as shingles), which results from virus shedding into the skin (Arvin, 1996; Goldblatt, 1998; Arvin, 2001).”
BackgroundMembrane fusion mediated by herpesvirus glycoproteins: the paradigm of varicella-zoster virus
Cole, N. L., & Grose, C. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.377 · Cited by 112
Overcoming immune dysfunction in the elderly: trained immunity as a novel approach
Bulut, O., Kilic, G., Domínguez-Andrés, J., & Netea, M. G. (2020) · International Immunology · doi:10.1093/intimm/dxaa052 · Cited by 99
Single-Cell Mass Cytometry Analysis of Human Tonsil T Cell Remodeling by Varicella Zoster Virus
Sen, N., Mukherjee, G., Sen, A., Bendall, S. C., Sung, P., Nolan, G. P., & Arvin, A. M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.024 · Cited by 90
Self-citationEffects of radiation and latent virus on immune responses in a space flight model
Shearer, W. T., Zhang, S., Reuben, J. M., Lee, B.-N., & Butel, J. S. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.03.003 · Cited by 34
Metadata
- Authors
- Arvin, A. M.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1996-07
- Volume
- 9
- Issue
- 3
- Pages
- 361-381
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2140319515
- Cited by
- 1,162
- References
- 145
- FWCI
- 23.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.